Presenting MX100 Innovative Startups - Transhumangene AI, Vocalis, and Sondehealth
Are you ready for the big event that ends the year resoundingly and with style? Be ready to join MX100
MX100 - Dec, 20. 2022
Burj Khalifa, Dubai
MX100 is an unique event that reunites 100 Innovative Startups from different areas of #technology
#medtech
#edtech
#agrotech
#fintechnews
Here are some of the 100 Startups that are in our focus:
Transhumangene AI
Given the pressing need to determine whether anti-COVID-19 vaccines will be effective or not, given the rapid spread of the so-called variants of concern, understanding and modeling the mutational landscape of SARS-CoV-2 is of utmost relevance for Transhumanegene AI.
The supercomputing-driven platform for predicting the effects of medications on COVID patients was created by the author of Strong AI, who also collaborates with teams from the fields of AI and biotechnology.
Vocalis
Vocalis have another product that is focused on respiratory disease identification and monitoring and are currently working on employing voice biomarkers to identify the possibility of hospitalization for a number of ailments. In light of this history, it is not surprising that the corporation has played a significant part in the healthcare sector's reaction to the coronavirus pandemic.
Sondehealth
Chief Executive Officer of Sonde Health is David Liu. A digital health business called Sonde Health is using voice-based solutions to revolutionize the way we track and diagnose our physical and mental health.
